ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 736201 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 736201; 2) Community: the network communities that were significantly associated with the response to NSC 736201; 3) Molecule: the relationships between components within communities and NSC 736201; 4) MDR: the compounds that were significantly associated with the NSC 736201.

NSC Compound Enrichment Correlation
NSC 645665 Null 0.0352383000003056 0.25587958
NSC 649904 Cyclopentanone, 5-[(4-morpholinyl)methyl]-2-pentylidene-, hydrochloride 0.0352383000003056 0.38361671
NSC 679006 2-Butenedioic acid, 2,2'-(5-methyl-2,4-dioxopyrimidine- 1,3-diyl)bis-, tetraethyl ester 0.0352383000003056 0.22039922
NSC 681641 Camptothecin Derivative 0.0352383000003056 0.76217529
NSC 682095 Quinolinium, 1,1'-(1,10-decanediyl)bis[4-(dimethylamino)- 2-methyl-, diperchlorate 0.0352383000003056 0.20606016
NSC 684043 1H-Imidazole-4-carboxamide, 5-[[(2-amino-2-carboxyethyl)thio]azo]- 0.0352383000003056 0.37378987
NSC 687793 Null 0.0352383000003056 0.22463161
NSC 692574 Null 0.0352383000003056 0.33030607
NSC 693207 Null 0.0352383000003056 0.19765035
NSC 694001 2-Butenedioic acid, (E)-, 2-[3-[[[4-(acetyloxy)butyl]- 1H-1,2,3-triazol-4-yl]methyl]-1,2,3,4-tetrahydro-5-methyl-2,4-dioxo-1-pyrimidinyl]-, diethyl ester 0.0352383000003056 0.25885731
Total:108  Current:76    [First] [Prev] [Next] [Last]